BMS secures FDA accelerated approval for Zenbexus in multiple myeloma
The FDA has granted accelerated approval to BMS' Zenbexus, along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma.
Read the full article on the original site.
Read Full Article